Except for those cancers [ACC, adrenocortical carcinoma; DLBC, diffuse large B-cell lymphoma; LAML, acute myeloid leukaemia; LGG, brain lower grade glioma; MESO, mesothelioma; OV, ovarian serous cystadenocarcinoma; SARC, sarcoma; TGCT, testicular germ cell tumour; THYM, thymoma; UCS Uterine Carcinosarcoma; UVM, uveal melanoma] for which normal tissue data were unavailable or too limited, significant differences in BARX2 expression between tumour and normal tissue were found in 22 types of cancer. This evidence concerns the gene BARX2 and neoplasm.